Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis

Microvascular Research

Volumn 56, Issue 3, 1998, Pages 145-153

  Moore, Anna ^a   Marecos, Edgardo ^a   Simonova, Maria ^a   Weissleder, Ralph ^a   Bogdanov Jr , Alexei ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain tumor; Green fluorescent protein; Microvessel density; Tumor delineation

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; MICROVASCULATURE; MODEL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ANIMALIA;

EID: 0032212057     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1998.2102     Document Type: Article

References (45)

1. Abdulrauf S., Edvardsen K., Ho K., Yang X., Rock J., Rosenblum M. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J. Neurosurg. 88:1998;513-520.
2. Barbareschi M., Gasparini G., Morelli L., Forti S., Dalla Palma P. Novel methods for the determination og the angiogenic activity of human tumors. Breast Cancer Res. Treat. 36:1995;181-192.
3. Bastaki M., Nelli E., Dell'Era P., Rusnati M., Molinari-Tosatti M., Parolini S., Auerbach R., Ruco L., Possati L., Presta M. Basic fibroblast growth factor-induced angiogenic phenotype on mouse endothelium. A study of aortic and microvascular endothelial cell lines. Arterioscler. Thromb. Vasc. Biol. 17:1997;454-464.
4. Bonta I., Ben-Efraim S. Involvment of inflammatory mediators in macrophage antitumor activity. J. Leukocyte Biol. 54:1993;613-626.
5. Brem S., Tsanaclis A., Zagzag D. Anticopper treatment inhibits pseudopodial protrusion and the invasive spread of 9L gliosarcoma cells in the rat brain. Neurosurgery. 26:1990;391-396.
6. Chalfie M., Tu Y., Euskirchen G., Ward W., Prasher D. Green fluorescent protein as a marker gor gene expression. Science. 263:1994;802-805.
7. Chishima T., Miyagi Y., Wang X., Tan Y., Shimada H., Moossa A., Hoffman R. Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res. 17:1997;2377-2384.
8. Esiri M., McGee J. Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglial cells in human brain. J. Clin. Pathol. 39:1986;615-621.
9. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:1995;27-31.
10. Folkman J. Tumor angiogenesis and tissue factor. Nature Med. 2:1996;167-168.
11. Gabryel-Grudziak A., Boggs S., Redgate E., Deutsch M. lacZ transduction of 9L rat tumor cells without cloning. Tumor Biol. 18:1997;321-331.
12. Grignani F., Kinsella T., Mencarelli A., Valtieri M., Riganelli D., Grignani F., Lanfrancone L., Peschle C., Nolan G., Pelicci P. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58:1998;14-19.
13. Haas J., Park E. C., Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6:1996;315-324.
14. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
15. Hansen S., Grabau D., Bak M., Rose C., Sorensen F. Estimating intratumoral microvessel density by different methods to determine angiogenesis in breast cancer: Intra- and interobserver variability. Angiogen Cancer. 1998.
16. Higashijima S., Okamoto H., Ueno N., Hotta Y., Eguchi G. High-frequency generation of transgenic zebrafish which reliably express GFP in whole muscles or the whole body by using promoters of zebrafish origin. Dev. Biol. 192:1997;289-299.
17. Jain R. The Eugene M Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors. Microcirculation. 4:1997;1-23.
18. Jain R., Schlenger K., Hockel M., Yuan F. Quantitative angiogenesis assays: Progress and problems. Nature Med. 3:1997;1203-1208.
19. Jakoby W., Pastan I. Cell culture. Methods Enzymol. 58:1979.
20. Kaku T., Kamura T., Kinukawa N., Kobayashi H., Sakai K., Tsuruchi N., Saito T., Kawauchi S., Tsuneyoshi M., Nakano H. Angiogenesis in endometrial carcinoma. Cancer. 80:1997;741-747.
21. Lampson L., Lampson M., Dunne A. Exploiting the lacZ reporter gene for quantitative analysis of disseminated tumor growth wothin the brain: The use of the lacZ gene product as a tumor antigen for evaluation of antigenic modulation and to facilitate image analysis of tumor growth in situ. Cancer Res. 53:1993;176-180.
22. Lampson L., Wen P., Roman V., Morris J., Sarid J. Dissiminating tumor cells and their interactions with leukocyres visualized in the brain. Cancer Res. 52:1992;1018-1025.
23. Leffel S., Mabon S., Stewart C. Application of green fluorescent protein in plants. Biotechniques. 23:1997;912-918.
24. Leung S., Wong M., Chung L., Chan A., Yuen S. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. 93:1997;518-527.
25. Levin E., Santell L., Osborn K. The expression of endothelial tissue plasminogen activator in vivo: A function defined by vessel size and anatomic location. J. Cell Sci. 110:1997;139-148.
26. Lichtenbeld H., Yuan F., Michel C., Jain R. Perfusion of single tumor microvessels:application to vascular permeability measurment. Microcirculation. 3:1996;349-357.
27. Martin L., Green B., Renshaw C., Lowe D., Rudland P., Leinster S., Winstanley J. Examining the technique of angiogenesis assessment in invasive breast cancer. Br. J. Cancer. 76:1997;1046-1054.
28. Morimura T., Neuchrist C., Kitz K., Budka H., Scheiner O., Kraft D., Lassmann H. Monocyte subpopulations in human gliomas: Expression of Fc and complement receptors and correlation with tumor prolifiration. Acta Neuropathol. 80:1990;287-294.
29. Nemati M., Stan A., Putz K., Pietsch T., Walter G., Dietz H. Inhibition of angiogenesis and gfowth of malignant gliomas in the athymic nude rat model: Immunotherapy against basic fibroblast growth factor. Zentralbl. Neurochir. 57:1996;12-19.
30. Plate K., Breier G., Millauer B., Ullrich A., Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat model of tumor angiogenesis. Cancer Res. 53:1993;5822-5827.
31. Pries A., Schonfeld D., Gaehtgens P., Kiani M., Cokelet G. Diameter variability and microvascular flow resistance. Am. J. Physiol. 272:1997;H2716-H2725.
32. Samoto K., Ikezaki K., Ono M., Shono T., Kohno K., Kuwano M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 55:1995;1189-1193.
33. Scharf J., Boviatsis E., Fleet C., Breakefield X., Chiocca E. Genetically modified rat 9L gliosarcoma cells facilitate detection of infiltrating tumor cells in a rat model of brain neoplasms. Transgenics. 1:1994;219-224.
34. Smith K., Hill S., Begg A., Denekamp J. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumors. Br. J. Cancer. 57:1988;247-253.
35. Tamargo R., Leong K., Brem H. Growth inhibition og the 9L glioma using polymers to release heparin and cortisone acetate. J. Neuro-Oncol. 9:1990;131-138.
36. Tanigawa N., Lu C., Mitsui T., Miura S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: Its clinical and prognostic significance. Hepatology. 26:1997;1216-1223.
37. Viola J., Ram Z., Walbridge S., Oshiro E., Trapnell B., Tao-Cheng J., Oldfield E. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells. J. Neurosur. 82:1995;70-76.
38. Weidner N., Folkman J. Tumor vascularity as a prognostic factor in cancer. Important Adv. Oncol. 26:1996;167-190.
39. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E., Moore D., Meli S., Gasparini G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Int. 84:1992;1875-1887.
40. Weizsaecker M., Deen D., Rosenblum M., Hoshino T., Gutin P., Barker M. The 9L rat brain tumor: Description and applicatopn of an animal model. J. Neurol. 224:1981;183-192.
41. Wheeler K., Tel N., Williams M., Sheppard S., Levin V., Kabra P. Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 35:1975;1464-1469.
42. Wolff J., Guerin C., Laterra J., Bressler J., Indurti R., Brem H., Goldstein G. Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res. 604:1993;79-85.
43. Wolff J., Molenkamp G., Hotfilder M., Laterra J. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo. Klin. Padiatr. 209:1997;275-277.
44. Zhang L., Yoshimura T., Graves D. Antibody to Mac-1 or monocyte chemoattractant protein-1 inhibits monocyte recruitment and promotes tumor growth. J. Immunol. 158:1997;4855-4861.
45. Zolotukhin S., Potter M., Hauswirth W., Guy J., Muzyczka N. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:1996;4646-4654.